Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Chronic Inducible Urticaria

Immunology

Immunology Video Recap—February 25, 2026

This biweekly Immunology video recap highlights key developments across…

Immunology

Immunology Today—February 25, 2026

This week's Immunology update summarizes covering clinical-trial readouts and…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Immunology Video Recap—February 25, 2026
Neuroscience Today—February 25, 2026
Immunology Today—February 25, 2026
Lucid Diligence Brief: Astellas collaboration with Vir Biotechnology
Endocrinology Video Recap—February 24, 2026

Tags

AAVantgarde Bio Acute Myeloid Leukemia Air Quality Aldevron BeOne Medicines BioCardia Candida albicans Cardiovascular News Cellectis China biotech cladribine thin-film concizumab COVID prevention EASO obesity guideline EndoQuest Robotics endpoint technology etripamil EU regulatory facioscapulohumeral muscular dystrophy Fucaso genetic medicines GenomeDx GLP-1s Immunic Therapeutics IND enabling ipilimumab LEQEMBI Limb-Girdle Muscular Dystrophy Lundbeck Metastatic melanoma multi-omics NACFC ObesityWeek pediatric AD PFIC Phase 3 clinical trial pulmonary arterial hypertension Relapsing multiple sclerosis Remyelination SGAustria SNUH Theravance Biopharma tulisokibart venetoclax Wayrilz

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Immunology Video Recap—February 25, 2026
Neuroscience Today—February 25, 2026
Immunology Today—February 25, 2026
Lucid Diligence Brief: Astellas collaboration with Vir Biotechnology
Endocrinology Video Recap—February 24, 2026

TAGS

AAVantgarde Bio Acute Myeloid Leukemia Air Quality Aldevron BeOne Medicines BioCardia Candida albicans Cardiovascular News Cellectis China biotech cladribine thin-film concizumab COVID prevention EASO obesity guideline EndoQuest Robotics endpoint technology etripamil EU regulatory facioscapulohumeral muscular dystrophy Fucaso genetic medicines GenomeDx GLP-1s Immunic Therapeutics IND enabling ipilimumab LEQEMBI Limb-Girdle Muscular Dystrophy Lundbeck Metastatic melanoma multi-omics NACFC ObesityWeek pediatric AD PFIC Phase 3 clinical trial pulmonary arterial hypertension Relapsing multiple sclerosis Remyelination SGAustria SNUH Theravance Biopharma tulisokibart venetoclax Wayrilz

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy